drugset / Trial / NCT01765868
A Human Phase I Absolute Bioavailability Study of PRT054021 in Healthy Male Volunteers
NaSingle-groupOpen-labelBasic science
Summary
This is a open label, single center, single oral dose, study of PRT054021, in healthy subjects.
Timeline
- Start
- 2007-09
- Primary completion
- 2007-10
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Betrixaban | Small molecule | 80 ug | Oral |
| Subject | Betrixaban | Small molecule | 80 mg | Oral |
Indications
No indication recorded.